{'fraction_non_alphanumeric': 0.024299065420560748, 'fraction_numerical': 0.0, 'mean_word_length': 6.444444444444445, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Vincristine‐induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia

Vincristine, an essential component of childhood acute lymphoblastic leukaemia (ALL) therapeutic protocols, is associated with dose‐dependent neurotoxicity, but its long‐term morbidity in treated children has not been clearly elucidated. The aim of this study is to determine the prevalence of vincristine‐induced peripheral neuropathy (VIPN) among Malaysian childhood ALL survivors and its impact on motor function and quality of life.